Zhongyuan Union Cell & Gene Eng
2
77M
2
0.07
1
1
- Areas of investment
Summary
The leading representative office of defined Corporate Investor is situated in the Tianjin. The venture was found in Asia in China.
Among the most popular portfolio startups of the fund, we may highlight iCarbonX, Genetron Health. For fund there is a match between the location of its establishment and the land of its numerous investments - China. The fund has no exact preference in a number of founders of portfolio startups. Among the most successful fund investment fields, there are Artificial Intelligence, Biotechnology. Besides, a startup needs to be aged 2-3 years to get the investment from the fund.
The top activity for fund was in 2016. The fund is constantly included in less than 2 investment rounds annually. Deals in the range of more than 100 millions dollars are the general things for fund. The typical startup value when the investment from Zhongyuan Union Cell & Gene Eng is more than 1 billion dollars.
The usual cause for the fund is to invest in rounds with 2-3 partakers. The meaningful sponsors for the fund in investment in the same round are Tencent Holdings, Share Capital, New Horizon Capital. In the next rounds fund is usually obtained by Zhongjin Kangrui Medical Industrial Fund, Vivo Capital, V Star Capital.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 1
- Exits
- 1
- Rounds per year
- 0.07
- Investments by industry
- Health Care (2)
- Clinical Trials (1)
- Medical Device (1)
- Medical (1)
- Machine Learning (1) Show 2 more
- Investments by region
-
- China (2)
- Peak activity year
- 2016
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Avg. valuation at time of investment
- 600M
- Group Appearance index
- 1.00
- Strategy success index
- 0.57
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| iCarbonX | 13 Apr 2016 | Biotechnology, Artificial Intelligence, Machine Learning, Health Care | Early Stage Venture | 155M | Guangdong Province, Futian District, China |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.